{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:24:36Z","timestamp":1769037876213,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H02829"],"award-info":[{"award-number":["21H02829"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00520-025-10264-8","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:07:38Z","timestamp":1766498858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of systemic opioid prescribing patterns for dyspnea in opioid-na\u00efve cancer patients: a secondary analysis of a multicenter observational study in Japan"],"prefix":"10.1007","volume":"34","author":[{"given":"Masashi","family":"Iida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozue","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Tanaka-Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"1","key":"10264_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jpainsymman.2005.06.007","volume":"31","author":"JP Solano","year":"2006","unstructured":"Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 31(1):58\u201369. https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.06.007","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"10264_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-001038","volume":"5","author":"D Hui","year":"2020","unstructured":"Hui D, Maddocks M, Johnson MJ, Ekstr\u00f6m M, Simon ST, Ogliari AC et al (2020) Management of breathlessness in patients with cancer: ESMO clinical practice guidelines. ESMO Open 5(6):e001038. https:\/\/doi.org\/10.1136\/esmoopen-2020-001038","journal-title":"ESMO Open"},{"issue":"12","key":"10264_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1200\/JCO.20.03465","volume":"39","author":"D Hui","year":"2021","unstructured":"Hui D, Bohlke K, Bao T, Campbell TC, Coyne PJ, Currow DC et al (2021) Management of dyspnea in advanced cancer: ASCO guideline. J Clin Oncol 39(12):1389\u20131411. https:\/\/doi.org\/10.1200\/JCO.20.03465","journal-title":"J Clin Oncol"},{"issue":"10","key":"10264_CR4","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1089\/jpm.2023.0667","volume":"27","author":"T Yamaguchi","year":"2024","unstructured":"Yamaguchi T, Matsuda Y, Watanabe H, Kako J, Kasahara Y, Goya S et al (2024) Treatment recommendation for dyspnea in patients with advanced disease: revised clinical guidelines from the Japanese Society for Palliative Medicine. J Palliat Med 27(10):1404\u20131414. https:\/\/doi.org\/10.1089\/jpm.2023.0667","journal-title":"J Palliat Med"},{"key":"10264_CR5","doi-asserted-by":"publisher","unstructured":"Yamaguchi T, Matsunuma R, Suzuki K, Matsuda Y, Mori M, Watanabe H (2019) The current practice of opioid for cancer dyspnea: the result from the nationwide survey of Japanese palliative care physicians. J Pain Symptom Manage 58(4):672\u20137.e2. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.06.006","DOI":"10.1016\/j.jpainsymman.2019.06.006"},{"issue":"3","key":"10264_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/0310057x0503300306","volume":"33","author":"EJ Murphy","year":"2005","unstructured":"Murphy EJ (2005) Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 33(3):311\u2013322. https:\/\/doi.org\/10.1177\/0310057x0503300306","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"10264_CR7","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.32636","volume":"16","author":"H Soleimanpour","year":"2016","unstructured":"Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM (2016) Opioid drugs in patients with liver disease: a systematic review. Hepat Mon 16(4):e32636. https:\/\/doi.org\/10.5812\/hepatmon.32636","journal-title":"Hepat Mon"},{"issue":"8","key":"10264_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/aas.12521","volume":"59","author":"GP Kurita","year":"2015","unstructured":"Kurita GP, Lundstr\u00f6m S, Sj\u00f8gren P, Ekholm O, Christrup L, Davies A et al (2015) Renal function and symptoms\/adverse effects in opioid-treated patients with cancer. Acta Anaesthesiol Scand 59(8):1049\u20131059. https:\/\/doi.org\/10.1111\/aas.12521","journal-title":"Acta Anaesthesiol Scand"},{"issue":"5","key":"10264_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jpainsymman.2022.12.146","volume":"65","author":"T Yamaguchi","year":"2023","unstructured":"Yamaguchi T, Matsunuma R, Matsuda Y, Tasaki J, Ikari T, Miwa S et al (2023) Systemic opioids for dyspnea in cancer patients: a real-world observational study. J Pain Symptom Manage 65(5):400\u2013408. https:\/\/doi.org\/10.1016\/j.jpainsymman.2022.12.146","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10264_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4037\/ajcc1998.7.3.200","volume":"7","author":"AG Gift","year":"1998","unstructured":"Gift AG, Narsavage G (1998) Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 7(3):200\u2013204. https:\/\/doi.org\/10.4037\/ajcc1998.7.3.200","journal-title":"Am J Crit Care"},{"issue":"8","key":"10264_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0269216319854264","volume":"33","author":"FE Murtagh","year":"2019","unstructured":"Murtagh FE, Ramsenthaler C, Firth A, Groeneveld EI, Lovell N, Simon ST et al (2019) A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS). Palliat Med 33(8):1045\u20131057. https:\/\/doi.org\/10.1177\/0269216319854264","journal-title":"Palliat Med"},{"issue":"5","key":"10264_CR12","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1037\/t46823-000","volume":"50","author":"N Yokomichi","year":"2015","unstructured":"Yokomichi N, Morita T, Nitto A, Takahashi N, Miyamoto S, Nishie H et al (2015) Validation of the Japanese version of the Edmonton Symptom Assessment System-Revised. J Pain Symptom Manage 50(5):718\u2013723. https:\/\/doi.org\/10.1037\/t46823-000","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10264_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jjco\/hyy203","volume":"49","author":"H Sakurai","year":"2019","unstructured":"Sakurai H, Miyashita M, Imai K, Miyamoto S, Otani H, Oishi A et al (2019) Validation of the integrated palliative care outcome scale (IPOS) - Japanese version. Jpn J Clin Oncol 49(3):257\u2013262. https:\/\/doi.org\/10.1093\/jjco\/hyy203","journal-title":"Jpn J Clin Oncol"},{"issue":"17","key":"10264_CR14","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1002\/cncr.29437","volume":"121","author":"D Hui","year":"2015","unstructured":"Hui D, Shamieh O, Paiva CE, Perez-Cruz PE, Kwon JH, Muckaden MA et al (2015) Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: a prospective, multicenter study. Cancer 121(17):3027\u20133035. https:\/\/doi.org\/10.1002\/cncr.29437","journal-title":"Cancer"},{"issue":"6","key":"10264_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jjco\/hyac034","volume":"52","author":"J Eba","year":"2022","unstructured":"Eba J, Nakamura K (2022) Overview of the ethical guidelines for medical and biological research involving human subjects in Japan. Jpn J Clin Oncol 52(6):539\u2013544. https:\/\/doi.org\/10.1093\/jjco\/hyac034","journal-title":"Jpn J Clin Oncol"},{"issue":"5 Suppl","key":"10264_CR16","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jpainsymman.2005.01.010","volume":"29","author":"E Kalso","year":"2005","unstructured":"Kalso E (2005) Oxycodone. J Pain Symptom Manage 29(5 Suppl):S47-56. https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.01.010","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10264_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0885-3924(97)00020-1","volume":"14","author":"M Ashby","year":"1997","unstructured":"Ashby M, Fleming B, Wood M, Somogyi A (1997) Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients. J Pain Symptom Manage 14(3):157\u2013167. https:\/\/doi.org\/10.1016\/s0885-3924(97)00020-1","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10264_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/clpt.1993.127","volume":"54","author":"R Osborne","year":"1993","unstructured":"Osborne R, Joel S, Grebenik K, Trew D, Slevin M (1993) The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clin Pharmacol Ther 54(2):158\u2013167. https:\/\/doi.org\/10.1038\/clpt.1993.127","journal-title":"Clin Pharmacol Ther"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10264-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:47:11Z","timestamp":1768985231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10264-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10264"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10264-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval for the original study was granted by the IRB of Kinki-Chuo Chest Medical Center (approval no. 2019-042), and the secondary analysis was approved by the Ethics Committee of Konan Medical Center (approval no. 2025-12).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent from patients was waived due to the observational nature of the study, as approved by the respective ethics committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}